HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA

Aim. To evaluate an influence of carvedilol on risk of hypoglycemia in patients with diabetes type 2 (D2) and chronic heart failure (CHF) treated with angiotensin converting enzyme (ACE) inhibitors.Material and methods. 13 patients (10 men, 3 women; aged 59,8±6,7 y.o.) with D2 and CHF caused by isch...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova
Format: Artigo
Jezik:Inglês
Izdano: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Serija:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Teme:
diabetes
chronic heart failure
hypoglycaemia
carvedilol
Online dostop:https://www.rpcardio.com/jour/article/view/1112
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki